Our Strategy
Corporate Information
Our Strategy
       Interview with FinTV
       Update of Relocation Progress of
           Manufacturing Plants of Grand
           Pharm (China)
       Hexun conversations with China
           Grand Pharm CEO
       Acquisition of Wuhan Kernel,
           a long-term strategic development
           to benefit of China Grand Pharm
Announcements and Circulars
Financial Reports
TodayIR Showcase (link)
Useful Links

Interview with FinTV

Date: 9/1/2013
Dr. Shao Yan, the CEO of China Grand Pharmaceutical and Healthcare Holdings Limited has interviewed by FinTV, one of the well known financial information provider in China and Hong Kong.

During the interview, Dr. Shao shared the development of cardiovascular and ophthalmic products of China Grand Pharm, analysis of the trends of the current healthcare market in China, including the impact of reformation of pharmaceutical industry, how to become a pioneer in such competitive pharmaceutical industry in China, and the recent acquisition of equity interest of Grand Pharm (China) and so on.

Source: FinTV


© 2019 China Grand Pharmaceutical and Healthcare Holdings Limited. All Rights Reserved. Disclaimer Powered by EQS TodayIR